User profiles for Zofia Mazerska

Zofia Mazerska

Profesor nauk farmaceutycznych, Politechnika Gdanska
Verified email at pg.edu.pl
Cited by 1206

The impact of lipophilicity on environmental processes, drug delivery and bioavailability of food components

…, A Kot-Wasik, J Namieśnik, Z Mazerska - Microchemical …, 2019 - Elsevier
Lipophilic properties of the compound allow to predict its fate in living organisms and to
propose the models of chemicals transport and accumulation in the ecosystem. Lipophilicity is …

The role of glucuronidation in drug resistance

Z Mazerska, A Mróz, M Pawłowska… - Pharmacology & …, 2016 - Elsevier
The final therapeutic effect of a drug candidate, which is directed to a specific molecular target
strongly depends on its absorption, distribution, metabolism and excretion (ADME). The …

State of the art and prospects of methods for determination of lipophilicity of chemical compounds

…, T Chmiel, A Kot-Wasik, A Mróz, Z Mazerska… - TrAC Trends in …, 2019 - Elsevier
Lipophilicity of the compounds is useful to (i) explain their distribution in biological systems,
which is different in plant and in animal organisms, (ii) predict the possible pathways of …

New unsymmetrical bisacridine derivatives noncovalently attached to quaternary quantum dots improve cancer therapy by enhancing cytotoxicity toward cancer cells …

…, A Kowalczyk, P Bujak, Z Mazerska… - … applied materials & …, 2020 - ACS Publications
The use of nanoparticles for the controlled drug delivery to cells has emerged as a good
alternative to traditional systemic delivery. Quantum dots (QDs) offer potentially invaluable …

Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles

…, AM Nowicka, A Kowalczyk, Z Stojek, Z Mazerska - Toxicology in Vitro, 2016 - Elsevier
A promising strategy for overcoming the problem of limited efficacy in antitumor drug
delivery and in drug release is the use of a nanoparticle-conjugated drug. Doxorubicin (Dox) …

Design, synthesis and high antitumor potential of new unsymmetrical bisacridine derivatives towards human solid tumors, specifically pancreatic cancers and their …

…, E Augustin, J Konopa, Z Mazerska - European Journal of …, 2020 - Elsevier
New promising unsymmetrical bisacridine derivatives (UAs), have been developed. Three
groups including 36 compounds were synthesized by the condensation of 4-nitro or 4-…

Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for …

…, R Chu, B Fedejko-Kap, E Augustin, Z Mazerska… - Drug Metabolism and …, 2013 - ASPET
The acridinone derivates 5-dimethylaminopropylamino-8-hydroxytriazoloacridinone (C-1305)
and 5-diethylaminoethylamino-8-hydroxyimidazoacridinone (C-1311) are promising …

Progress in targeting tumor cells by using drug-magnetic nanoparticles conjugate

…, P Krysinski, Z Stojek, E Augustin, Z Mazerska - …, 2013 - ACS Publications
To limit cytotoxicity of anticancer drugs against healthy cells, an appropriate carrier should
be synthesized to deliver the drug to the tumor tissue only. A good solution is to anchor a …

Molecular mechanism of the enzymatic oxidation investigated for imidazoacridinone antitumor drug, C-1311

Z Mazerska, P Sowiński, J Konopa - Biochemical pharmacology, 2003 - Elsevier
The imidazoacridinone derivative, C-1311, is an antitumor agent that has been under phase
I of clinical trial. The work presented here aims to elucidate the molecular mechanism of the …

Electroanalytical and spectroscopic procedures for examination of interactions between double stranded DNA and intercalating drugs

AM Nowicka, E Zabost, M Donten, Z Mazerska… - Analytical and …, 2007 - Springer
A method is presented for the electroanalytical characterization of interactions of dsDNA
with a drug, under conditions that both agents are dissolved in the phosphate buffer solution …